Despite the mounting death toll of America’s opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone–the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health. Notably, just six […]Continue Reading ...
FRIDAY, Jan. 11, 2019 — Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery. Jessica D. McDermott, M.D., from the University of Colorado Anschutz School of Medicine in Aurora, and colleagues used […]Continue Reading ...
It’s one of the first questions asked by many newly-diagnosed cancer patients–“What are my chances of beating this?” Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options. However, post-operative testing that provides an accurate prediction of long-term treatment outcomes is the next best thing […]Continue Reading ...
January 3, 2019 — Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to severe alopecia areata, a chronic autoimmune skin disease that causes hair loss on the scalp, face, or body, and currently has no approved […]Continue Reading ...
Penn Highlands Healthcare is the first medical facility in the region to offer bronchoscopic lung volume reduction using the first lung valve approved by the U.S. Food and Drug Administration for helping emphysema patients breathe easier without major surgery. The Zephyr Endobronchial Valve, which recently was approved by the FDA under “Breakthrough Devices” status, is […]Continue Reading ...
There are important lessons to be learned from the successes and failures of the AIDS response that could inform our response to the opioid epidemic, according to a new paper by researchers at the Columbia University Mailman School of Public Health. Decades of HIV research have demonstrated that the existence of an effective biomedical treatment […]Continue Reading ...
(HealthDay)—Among patients with obstructive sleep apnea, older age and reduced body mass index (BMI) are predictors of upper airway stimulation (UAS) treatment response, according to a study published online Nov. 28 in the European Respiratory Journal. Clemens Heiser, M.D., from Munich Technical University in Germany, and colleagues sought to identify predictors of UAS therapy response […]Continue Reading ...
(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday. Elzonris (tagraxofusp-erzs) infusion was granted the first approval for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children aged 2 years and older. Researchers investigated the efficacy of […]Continue Reading ...
Treatment for Transthyretin Familial Amyloid Polyneuropathy; Transthyretin Cardiomyopathy US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy January 14, 2019 – Pfizer Inc. (NYSE: PFE) announced today that the US Food and Drug Administration (FDA) accepted for filing the company’s New Drug Applications (NDAs) for tafamidis for the treatment of […]Continue Reading ...
Killer T cells surround a cancer cell. Credit: NIH Scientists at the University of Glasgow have discovered a potential combination therapy for the treatment of chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in the Western world, diagnosed in more than 3,500 people in the UK each year. The research, carried out in […]Continue Reading ...
Increasing evidence supports the use of empirically-derived algorithms that use symptom monitoring to guide ongoing treatment planning Adolescents with depression who were treated with interpersonal psychotherapy (IPT-A) had significantly better outcomes when their therapists regularly assessed depression symptoms and augmented treatment for insufficient responders after four weeks of therapy rather than waiting until Week 8, […]Continue Reading ...
Hoping to earn its share of the $3.5 trillion health care market, the medical industry is pouring more money than ever into advertising its products — from high-priced prescriptions to do-it-yourself genetic tests and unapproved stem cell treatments. Spending on health care marketing doubled from 1997 to 2016, soaring to at least $30 billion a […]Continue Reading ...
Treatment for Acne Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 21, 2018 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in […]Continue Reading ...
Functional model of electronic shutter eyeglasses. Credit: Fraunhofer IBMT, Bernd Müller The standard treatment for so-called lazy eye (amblyopia) in children is to cover the nonimpaired eye with a patch. This trains the impaired eye to work harder. Such therapy is successful only when the patient wears the eyepatch for the prescribed period of time. […]Continue Reading ...
Parkinson’s disease is a neurodegenerative disorder characterized by motor and nonmotor deficits majorly caused by the loss of dopaminergic cells in the Substantia Nigra pars compacta (SNc) as well as the destruction of nigrostriatal pathway. Despite the numerous advances in cutting-edge approaches for the treatment or prevention of PD, there still exists some obstacles that […]Continue Reading ...
- Liver Transplant Survival May Improve With Race Matching
- Study implicates hyperactive immune system in aging brain disorders
- Cancer Diagnosis May Quadruple Suicide Risk
- Parkinson’s disease experts devise a roadmap
- Research brings new hope to treating degenerative brain diseases
- Scientists pinpoint a set of molecules that wire the body weight center of the brain
- Researchers get close to developing elusive blood test for Alzheimer’s disease
- UCLA researchers demonstrate new technique to develop cancer-fighting T cells
- Researchers discover how cancer cells avoid genetic meltdown
- Exercise makes even the ‘still overweight’ healthier: study
- University of Utah to establish first-of-its-kind dark sky studies minor in the US
- School-based nutritional programs reduce student obesity
- Improved maternity care practices in the southern U.S. reduce racial inequities in breastfeeding
- New enzyme biomarker test indicates diseases and bacterial contamination
- Republican and Democratic governors have different visions to transform health care, say researchers
- Researchers discover that spin flips happen in only half a picosecond in the course of a chemical reaction
- Suicide Risk Up More Than Fourfold for Cancer Patients
- Doctors find 122 nails in Ethiopian’s stomach
- UV disinfection technology eliminates up to 97.7% of pathogens in operating rooms
- Researchers discover mechanism which drives leukemia cell growth